Ono Pharmaceuticals announced that nivolumab has been approved in Asia. It obtained the rights to nivolumab from Medarex in 2005. It is approved for use in patients with unresectable melanoma.
![](https://blogs.shu.edu/cancer/files/2014/06/seal.png)
Ono Pharmaceuticals announced that nivolumab has been approved in Asia. It obtained the rights to nivolumab from Medarex in 2005. It is approved for use in patients with unresectable melanoma.